Month: <span>April 2018</span>
Bringing the next generation of replicon RNA vaccines to the world
Tiba is a Boston-based biotechnology startup with a mission to create a new generation of vaccines and immunotherapies for human and animal disease. We bridge expertise in synthetic biology and chemistry to bring a safer, more potent, and more cost-effective product to the market. Our vision is a world where […]